These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17848519)

  • 1. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation.
    Grassi F; Tell G; Robbie-Ryan M; Gao Y; Terauchi M; Yang X; Romanello M; Jones DP; Weitzmann MN; Pacifici R
    Proc Natl Acad Sci U S A; 2007 Sep; 104(38):15087-92. PubMed ID: 17848519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo.
    Roggia C; Gao Y; Cenci S; Weitzmann MN; Toraldo G; Isaia G; Pacifici R
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13960-5. PubMed ID: 11717453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMI-1 Mediates Estrogen-Deficiency-Induced Bone Loss by Inhibiting Reactive Oxygen Species Accumulation and T Cell Activation.
    Li J; Wang Q; Yang R; Zhang J; Li X; Zhou X; Miao D
    J Bone Miner Res; 2017 May; 32(5):962-973. PubMed ID: 27943387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.
    Cenci S; Weitzmann MN; Roggia C; Namba N; Novack D; Woodring J; Pacifici R
    J Clin Invest; 2000 Nov; 106(10):1229-37. PubMed ID: 11086024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss.
    Tyagi AM; Srivastava K; Kureel J; Kumar A; Raghuvanshi A; Yadav D; Maurya R; Goel A; Singh D
    Osteoporos Int; 2012 Mar; 23(3):1151-61. PubMed ID: 21562872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha mediates osteopenia caused by depletion of antioxidants.
    Jagger CJ; Lean JM; Davies JT; Chambers TJ
    Endocrinology; 2005 Jan; 146(1):113-8. PubMed ID: 15388652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irradiation up-regulates CD80 expression through two different mechanisms in spleen B cells, B lymphoma cells, and dendritic cells.
    Torihata H; Ishikawa F; Okada Y; Tanaka Y; Uchida T; Suguro T; Kakiuchi T
    Immunology; 2004 Jun; 112(2):219-27. PubMed ID: 15147565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA4-Ig preserves thymus-derived T regulatory cells.
    Ahmadi SM; Hölzl MA; Mayer E; Wekerle T; Heitger A
    Transplantation; 2014 Dec; 98(11):1158-64. PubMed ID: 25269023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-α Inhibits FoxO1 by Upregulating miR-705 to Aggravate Oxidative Damage in Bone Marrow-Derived Mesenchymal Stem Cells during Osteoporosis.
    Liao L; Su X; Yang X; Hu C; Li B; Lv Y; Shuai Y; Jing H; Deng Z; Jin Y
    Stem Cells; 2016 Apr; 34(4):1054-67. PubMed ID: 26700816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
    Mukherjee S; Ahmed A; Nandi D
    J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
    J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency.
    Roggia C; Tamone C; Cenci S; Pacifici R; Isaia GC
    Minerva Med; 2004 Apr; 95(2):125-32. PubMed ID: 15272247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen regulation of immune cell bone interactions.
    Weitzmann MN; Pacifici R
    Ann N Y Acad Sci; 2006 Apr; 1068():256-74. PubMed ID: 16831927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-α mediates the stimulation of sclerostin expression in an estrogen-deficient condition.
    Kim BJ; Bae SJ; Lee SY; Lee YS; Baek JE; Park SY; Lee SH; Koh JM; Kim GS
    Biochem Biophys Res Commun; 2012 Jul; 424(1):170-5. PubMed ID: 22735261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies.
    Tyagi AM; Mansoori MN; Srivastava K; Khan MP; Kureel J; Dixit M; Shukla P; Trivedi R; Chattopadhyay N; Singh D
    J Bone Miner Res; 2014 Sep; 29(9):1981-92. PubMed ID: 24677326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine lactoferrin improves bone status of ovariectomized mice via immune function modulation.
    Malet A; Bournaud E; Lan A; Mikogami T; Tomé D; Blais A
    Bone; 2011 May; 48(5):1028-35. PubMed ID: 21303707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.
    Abdallah BM; Ditzel N; Mahmood A; Isa A; Traustadottir GA; Schilling AF; Ruiz-Hidalgo MJ; Laborda J; Amling M; Kassem M
    J Bone Miner Res; 2011 Jul; 26(7):1457-71. PubMed ID: 21308776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion.
    Butts CL; Shukair SA; Duncan KM; Bowers E; Horn C; Belyavskaya E; Tonelli L; Sternberg EM
    Int Immunol; 2007 Mar; 19(3):287-96. PubMed ID: 17289656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
    Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
    Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4IG suppresses reactive oxygen species by preventing synovial adherent cell-induced inactivation of Rap1, a Ras family GTPASE mediator of oxidative stress in rheumatoid arthritis T cells.
    Remans PH; Wijbrandts CA; Sanders ME; Toes RE; Breedveld FC; Tak PP; van Laar JM; Reedquist KA
    Arthritis Rheum; 2006 Oct; 54(10):3135-43. PubMed ID: 17009234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.